Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 5, 2010, Pages 614-626

  Nick, Jerry A ^a,b   Chacon, Cathy S ^b   Brayshaw, Sara J ^a   Jones, Marion C ^c   Barboa, Christine M ^a   St Clair, Connie G ^a   Young, Robert L ^a,b   Nichols, David P ^a   Janssen, Jennifer S ^a,b   Huitt, Gwen A ^a   Iseman, Michael D ^a,b   Daley, Charles L ^a,b   Taylor Cousar, Jennifer L ^a,b   Accurso, Frank J ^c   Saavedra, Milene T ^a,b   Sontag, Marci K ^d  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Children's Hospital Colorado   (United States)

^d Global Health and Health Disparities   (United States)

Author keywords

Aged; Cystic fibrosis; Gender; Middle aged; Outcome assessment

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR PROTEIN, HUMAN;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CYSTIC FIBROSIS; DATA BASE; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; SURVIVOR; TREATMENT RESPONSE; AGE DISTRIBUTION; AGED; GENETICS; HOSPITALIZATION; MIDDLE AGED; ONSET AGE; PATIENT ATTITUDE; REGISTER; SEX RATIO; STATISTICS; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; COLORADO; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVORS;

EID: 77957712666     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201001-0092OC     Document Type: Article

References (79)

1. Sontag MK, Hammond KB, Zielenski J, Wagener JS, Accurso FJ. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes. J Pediatr 2005;147(3, Suppl)S83-S88.
2. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2007 annual data report to the center directors. Bethesda, MD: Cystic Fibrosis Foundation; 2008.
3. Hodson ME, Simmonds NJ, Warwick WJ, Tullis E, Castellani C, Assael B, Dodge JA, Corey M. International Study Of Aging In Cystic. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. J Cyst Fibros 2008;7:537-542.
4. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-S14.
5. Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003;9:498-503. (Pubitemid 37268214)
6. Highsmith WE, Overbeek SE, Hilvering C. A novel mutation in the CF gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994;331:974-980.
7. Sanders JS, Pryor TD, Wedel MK. Prolonged survival in an adult with cystic fibrosis. Chest 1980;77:226-227.
8. Fiel S. Cystic fibrosis in an adult. Emerg Med 1988;20:109-121.
9. Hunt B, Geddes D. Newly diagnosed CF in middle and later life. Thorax 1984;40:23-26.
10. Su C, Beanblossom B. Typical CF in an elderly woman. Am J Med 1989;86:701-703.
11. Rodman DM, Polis JM, Heltshe SL, Sontag MK, Chacon C, Rodman RV, Brayshaw SJ, Huitt GA, Iseman MD, Saavedra MT, et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2005;171:621-626.
12. Gan KH, Geus WP, Bakker W, Cornelis CBHW, Heijerman HGM. Genetic and clinical features of patients with cystic fibrosis diagnosed after the age of 16 years. Thorax 1995;50:1301-1304.
13. Keating CL, Liu X, Dimango EA. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest 2009;137:1157-1163.
14. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004;126:1215-1224.
15. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-652.
16. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-658.
17. Groman JD, Karczeski B, Sheridan M, Robinson TE, Fallin MD, Cutting GR. Phenotypic and genetic characterization of patients with features of "nonclassic" forms of cystic fibrosis. J Pediatr 2005;146:675-680.
18. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1475-1480.
19. Stewart B, Zabner J, Shuber AP, Welsh MJ, McCray PB Jr. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995;151:899-903.
20. McCloskey M, Redmond AO, Hill A, Elborn JS. Clinical features associated with a delayed diagnosis of cystic fibrosis. Respiration 2000;67:402-407.
21. Widerman E, Millner L, Sexauer W, Fiel S. Health status and sociodemographic characteristics of adults receiving a CF diagnosis after age 18 years. Chest 2000;118:427-433.
22. Simmonds NJ, Cullinan P, Hodson ME. Growing old with cystic fibrosis: the characteristics of long-term survivors of cystic fibrosis. Respir Med 2009;103:629-635.
23. Farrell P, Joffe S, Foley L, Canny GJ, Mayne P, Rosenberg M. Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs. Ir Med J 2007;100:557-560.
24. McCormick J, Sims EJ, Mehta A. Delayed diagnosis of females with respiratory presentation of cystic fibrosis did not segregate with poorer clinical outcome. J Clin Epidemiol 2006;59:315-322.
25. Lai HC, Kosorok MR, Laxova A, Makholm LM, Farrell PM. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol 2002;156:165-173.
26. Modolell I, Alvarez A, Guarner L, De Gracia J, Malagelada JR. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis. Pancreas 2001;22:395-399.
27. Cystic Fibrosis Genotype-Phenotype-Consortium. Correlation between genotype and phenotype in patients with CF. N Engl J Med 1993;329:1308-1313.
28. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, Detzer M, Brooks JG. Case-mix adjustment for evaluation of mortality in CF. Pediatr Pulmonol 2002;33:99-105.
29. Fogarty A, Hubbard R, Britton J. International comparison of median age at death from cystic fibrosis. Chest 2000;117:1656-1660.
30. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997;145:794-803.
31. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326:1187-1191.
32. Verma N, Bush A, Buchdahl R. Is there still a gender gap in cystic fibrosis? Chest 2005;128:2824-2834.
33. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2006 annual data report to the center directors. Bethesda, MD: Cystic Fibrosis Foundation; 2007.
34. Wolfenden LL, Schechter MS. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev 2009;10:32-36.
35. Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28:2141-2144.
36. van den Berg JM, Kouwenberg JM, Heijerman HG. Demographics of glucose metabolism in cystic fibrosis. J Cyst Fibros 2009;8:276-279.
37. Levy H, Kalish LA, Cannon CL, Garcia KC, Gerard C, Goldmann D, Pier GB, Weiss ST, Colin AA. Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients. Pediatr Pulmonol 2008;43:463-471.
38. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003;35:257-262.
39. Demko CA, Byard PJ, Davis PB. Gender differences in CF: Pseudomonas aeruginosa infection. J Clin Epidemiol 1994;43:125-131.
40. Grasemann H, Storm van's Gravesande K, Buscher R, Drazen JM, Ratjen F. Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide. Am J Respir Crit Care Med 2003;167:1113-1116.
41. Block JK, Vandemheen KL, Tullis E, Fergusson D, Doucette S, Haase D, Berthiaume Y, Brown N, Wilcox P, Bye P, et al. Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax 2006;61:969-974.
42. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000;137:374-380.
43. Pagtakhan RD, Bjelland JC, Landau LI, Loughlin G, Kaltenborn W, Seeley G, Taussig LM. Sex differences in growth patterns of the airways and lung parenchyma in children. J Appl Physiol 1984;56:1204-1210.
44. 2+- dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest 2008;118:4025-4035.
45. Patterson JM, Wall M, Berge J, Milla C. Associations of psychosocial factors with health outcomes among youth with cystic fibrosis. Pediatr Pulmonol 2009;44:46-53.
46. Czajkowski DR, Koocher GP. Medical compliance and coping with cystic fibrosis. J Child Psychol Psychiatry 1987;28:311-319.
47. Patterson JM, Wall M, Berge J, Milla C. Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire. J Cyst Fibros 2008;7:154-164.
48. Besier T, Schmitz TG, Goldbeck L. Life satisfaction of adolescents and adults with cystic fibrosis: impact of partnership and gender. J Cyst Fibros 2009;8:104-109.
49. Abbott J, Conway S, Etherington C, Fitzjohn J, Gee L, Morton A, Musson H, Webb AK. Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers. J Behav Med 2000;23:501-517.
50. Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001;53:1163-1174.
51. Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis. J Hum Nutr Diet 2001;14:83-91.
52. Arrington-Sanders R, Yi MS, Tsevat J, Wilmott RW, Mrus JM, Britto MT. Gender differences in health-related quality of life of adolescents with cystic fibrosis. Health Qual Life Outcomes 2006;4:5.
53. Myers LB. An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis. J Cyst Fibros 2009;8:425-427.
54. Centers for Disease Control and Prevention (CDC). Mortality data, multiple cause-of-death public-use data files. Hyattsville, MD: National Center for Health Statistics, Publications and Information Products; 2010.
55. Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, et al. Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009;155:S106-S116.
56. Nick J, Chacon C, Brayshaw S, Jones M, Barboa C, Young R, Janssen J, Gleeksman C, Huitt G, Iseman M, et al. Diagnosis, patterns of care, and long-term survival in nonclassic CF patients [abstract]. Pediatr Pulmonol 2008;S31:402.
57. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:589-595.
58. McKone EF, Goss CH, Aitken ML. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 2006;130:1441-1447.
59. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-1676.
60. Arias E, Curtin LR, Wei R, Anderson R. US decennial life tables for 1999-2001, United States life tables. Natl Vital Stat Rep 2008;57:1-36.
61. Noone PG, Pue CA, Zhou Z, Friedman KJ, Wakeling EL, Ganeshananthan M, Simon RH, Silverman LM, Knowles MR. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am J Respir Crit Care Med 2000;162:1919-1924.
62. Weiss FU, Simon P, Bogdanova N, Mayerle J, Dworniczak B, Horst J, Lerch MM. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 2005;54:1456-1460.
63. Dray X, Fajac I, Bienvenu T, Chryssostalis A, Sogni P, Hubert D. Association of pancreas divisum and recurrent acute pancreatitis with the IVS8-5T-12TG allele of the CFTR gene and CFTR dysfunction. Pancreas 2007;35:90-93.
64. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res 1999;47:623-634.
65. DeLambo KE, Ievers-Landis CE, Drotar D, Quittner AL. Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. J Pediatr Psychol 2004;29:343-353.
66. Collins CE, O'Loughlin EV, Henry R. Discrepancies between males and females with cystic fibrosis in dietary intake and pancreatic enzyme use. J Pediatr Gastroenterol Nutr 1998;26:258-262.
67. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML; Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001;107:1-13.
68. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F1-F7.
69. Morea A, Cameran M, Rebuffi AG, Marzenta D, Marangon O, Picci L, Zacchello F, Scarpa M. Gender-sensitive association of CFTR gene mutations and 5T allele emerging from a large survey on infertility. Mol Hum Reprod 2005;11:607-614.
70. Strom CM, Crossley B, Redman JB, Buller A, Quan F, Peng M, McGinnis M, Sun W. Cystic fibrosis screening: lessons learned from the first 320,000 patients. Genet Med 2004;6:136-140.
71. Sun W, Anderson B, Redman J, Milunsky A, Buller A, McGinniss MJ, Quan F, Anguiano A, Huang S, Hantash F, et al. CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype. Genet Med 2006;8:339-345.
72. Kerem E, Rave-Harel N, Augarten A, Madgar I, Nissim-Rafinia M, Yahav Y, Goshen R, Bentur L, Rivlin J, Aviram M, et al. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations. Am J Respir Crit Care Med 1997;155:1914-1920.
73. Culard JF, Desgeorges M, Romey MC, Malzac P, Demaille J, Claustres M. A novel splice site mutation in the first exon of the cystic fibrosis transmembrane regulator (CFTR) gene identified in a CBAVD patient. Hum Mol Genet 1994;3:369-370.
74. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G, et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000;16:143-156.
75. Gilljam M, Moltyaner Y, Downey GP, Devlin R, Durie P, Cantin AM, Zielenski J, Tullis DE. Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med 2004;169:174-179.
76. Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr 2003;142:631-636.
77. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
78. Mahadeva R, Webb K, Westerbeek RC, Carroll NR, Dodd ME, Bilton D, Lomas DA. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-1775.
79. Collins CE, MacDonald-Wicks L, Rowe S, O'Loughlin EV, Henry RL. Normal growth in cystic fibrosis associated with a specialised centre. Arch Dis Child 1999;81:241-246. (Pubitemid 29398386)